Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 5601-5650 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT06503601
The Impact of Genetic Polymorphism on the Echocardiographic Parameters and Cardiac Fibrosis Markers in Response to Empagliflozin Treatment Among Patients With Heart Failure
N/A
Active, not recruiting
92 participants
Started: Jul 30, 2023 · Completed: Oct 1, 2025
1 condition
1 sponsor
1 location
NCT05944770
ASPIRE Health Tulare County
NA
Active, not recruiting
80 participants
Started: Jul 29, 2023 · Completed: Oct 31, 2023
2 conditions
2 sponsors
1 location
NCT05912023
Perioperative Vaping Complications
N/A
Active, not recruiting
300 participants
Started: Jul 28, 2023 · Completed: Jul 1, 2025
2 conditions
1 sponsor
1 location
NCT05935748
Ph2 Study NKT2152 with Palbociclib & Sasanlimab in Subjects with Advanced Clear Cell Renal Cell Carcinoma (ccRcc)
PHASE2
Active, not recruiting
172 participants
Started: Jul 28, 2023 · Completed: Jun 30, 2026
21 conditions
2 sponsors
8 locations
NCT05830838
Daily Adaptive Post-Prostatectomy With Stereotactic Ablative Radiotherapy in Patients With Prostate Cancer
NA
Active, not recruiting
50 participants
Started: Jul 28, 2023 · Completed: May 30, 2029
1 condition
1 sponsor
1 location
NCT06399315
Study of Single and Multiple Ascending Doses of ZE46-0134 in Healthy Volunteers
PHASE1
Active, not recruiting
112 participants
Started: Jul 28, 2023 · Completed: Oct 30, 2025
1 condition
1 sponsor
1 location
NCT05754528
Evaluating an Endocrine Therapy Dose-frequency Escalation Strategy and Its Effects on Tolerability and Compliance
PHASE4
Active, not recruiting
240 participants
Started: Jul 28, 2023 · Completed: Feb 28, 2030
1 condition
1 sponsor
2 locations
NCT05686356
A Pan-TB Regimen Targeting Host and Microbe
PHASE2/PHASE3
Active, not recruiting
352 participants
Started: Jul 28, 2023 · Completed: Jan 31, 2026
1 condition
9 sponsors
8 locations
NCT05853458
Evaluation of HU-resistance in Adult Patients With Polycythemia Vera Who Meet PV-AIM Predictors
PHASE4
Active, not recruiting
76 participants
Started: Jul 28, 2023 · Completed: Jan 27, 2027
1 condition
1 sponsor
26 locations
NCT05917509
A Study to Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral Therapy
PHASE3
Active, not recruiting
171 participants
Started: Jul 28, 2023 · Completed: Sep 3, 2026
1 condition
3 sponsors
47 locations
NCT05798507
Identification of Treatment Concentrations of Defactinib or VS-6766 for the Treatment of Patients With Glioblastoma
EARLY_PHASE1
Active, not recruiting
14 participants
Started: Jul 28, 2023 · Completed: Oct 31, 2026
2 conditions
3 sponsors
1 location
NCT06042049
A Study to Assess Safety, Pharmacokinetics Anti-Drug Antibody and Anti-RSV Antibody After 2 Doses of Nirsevimab
PHASE3
Active, not recruiting
33 participants
Started: Jul 27, 2023 · Completed: Aug 15, 2025
1 condition
2 sponsors
9 locations
NCT06185803
Predictors of Anterior Patellofemoral Pain After Anterior Cruciate Ligament Reconstruction
N/A
Active, not recruiting
500 participants
Started: Jul 27, 2023 · Completed: Jun 30, 2026
1 condition
2 sponsors
1 location
NCT07193316
Safety and Efficacy of Atezolizumab-Bevacizumab Versus Tyrosin Kinase Inhibitors in Patients With Liver Cirrhosis
N/A
Active, not recruiting
741 participants
Started: Jul 27, 2023 · Completed: Oct 31, 2025
2 conditions
1 sponsor
1 location
NCT05989711
IMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH)
PHASE2
Active, not recruiting
190 participants
Started: Jul 27, 2023 · Completed: Dec 30, 2025
1 condition
1 sponsor
40 locations
NCT05630066
A Study to Investigate the Pharmacokinetics (PK) and Safety and to Provide Proof of Mechanism of Alogabat in Children and Adolescents Aged 5-17 Years With Angelman Syndrome (AS) With Deletion Genotype.
PHASE2
Active, not recruiting
48 participants
Started: Jul 27, 2023 · Completed: Dec 4, 2025
1 condition
1 sponsor
20 locations
NCT05907122
A Study to Evaluate Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Melanoma
PHASE3
Active, not recruiting
256 participants
Started: Jul 26, 2023 · Completed: Nov 30, 2025
1 condition
1 sponsor
111 locations
NCT06315205
Evaluation of the Pharmacokinetics, Safety, and Tolerability of IM Letrozole LEBE in Healthy Post-menopausal Women
PHASE1
Active, not recruiting
90 participants
Started: Jul 26, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05842070
The Stanford Egg Freezing Study
NA
Active, not recruiting
100 participants
Started: Jul 26, 2023 · Completed: Jul 31, 2025
2 conditions
1 sponsor
1 location
NCT06185335
A Trial of the Safety and Efficacy of Single-Dose Administration of ANB-010 in Subjects With Hemophilia A
PHASE1/PHASE2
Active, not recruiting
50 participants
Started: Jul 26, 2023 · Completed: Jun 30, 2033
1 condition
1 sponsor
17 locations
NCT06078046
MOVIN' CARE for PD (Mind-body Interventions)
NA
Active, not recruiting
154 participants
Started: Jul 26, 2023 · Completed: Jun 11, 2027
1 condition
3 sponsors
1 location
NCT06147284
MOVIN' CARE for PD (Risk Management)
NA
Active, not recruiting
308 participants
Started: Jul 26, 2023 · Completed: Jun 11, 2027
1 condition
3 sponsors
1 location
NCT05510908
Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
N/A
Active, not recruiting
720 participants
Started: Jul 25, 2023 · Completed: Jul 31, 2025
8 conditions
2 sponsors
16 locations
NCT06870838
Neuroinflammation in FTLD
N/A
Active, not recruiting
110 participants
Started: Jul 25, 2023 · Completed: Aug 31, 2026
5 conditions
2 sponsors
2 locations
NCT05757713
Teplizumab in Pediatric Stage 2 Type 1 Diabetes
PHASE4
Active, not recruiting
20 participants
Started: Jul 25, 2023 · Completed: Aug 27, 2026
1 condition
1 sponsor
10 locations
NCT06488664
An Efficacy and Safety Study of GNR-068 (Ustekinumab Biosimilar) and Stelara® in the Treatment of Patients With Moderate to Severe Plaque Psoriasis
PHASE3
Active, not recruiting
422 participants
Started: Jul 25, 2023 · Completed: Sep 30, 2025
1 condition
1 sponsor
34 locations
NCT05964257
To Evaluate the Efficacy and Safety of LIZTOX in Subjects with Benign Masseteric Hypertrophy
PHASE3
Active, not recruiting
188 participants
Started: Jul 25, 2023 · Completed: May 30, 2025
1 condition
1 sponsor
1 location
NCT06763211
Effect of Chlorhexidine Gluconate Hair Bath on the Development of Surgical Site Infection and Time to Discharge
NA
Active, not recruiting
84 participants
Started: Jul 24, 2023 · Completed: Sep 30, 2025
1 condition
2 sponsors
1 location
NCT05903794
A Study of EXG102-031 in Patients With wAMD (Everest)
PHASE1
Active, not recruiting
12 participants
Started: Jul 24, 2023 · Completed: Feb 28, 2026
1 condition
1 sponsor
2 locations
NCT05772286
Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Protein SOSIP v8.2 763 Vaccine, Adjuvanted With MPLA Liposomes, in Healthy, HIV-Uninfected Adults
PHASE1
Active, not recruiting
12 participants
Started: Jul 24, 2023 · Completed: Jun 30, 2025
1 condition
2 sponsors
1 location
NCT05862727
Preschool Attention and Sleep Support (PASS)
NA
Active, not recruiting
46 participants
Started: Jul 24, 2023 · Completed: Jan 31, 2026
2 conditions
2 sponsors
1 location
NCT05776615
The Effect of the Mobile Application Developed for the Care of Sick Newborns
NA
Active, not recruiting
63 participants
Started: Jul 24, 2023 · Completed: Aug 15, 2024
2 conditions
1 sponsor
1 location
NCT05499975
Comprehensive Health Assessment for my Cancer Treatment Plan
NA
Active, not recruiting
180 participants
Started: Jul 24, 2023 · Completed: Jun 30, 2025
2 conditions
1 sponsor
3 locations
NCT05909046
A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP)
NA
Active, not recruiting
104 participants
Started: Jul 24, 2023 · Completed: Jun 30, 2025
6 conditions
1 sponsor
1 location
NCT05910528
Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease
PHASE2
Active, not recruiting
21 participants
Started: Jul 24, 2023 · Completed: Dec 31, 2030
1 condition
1 sponsor
11 locations
NCT05839873
Abbott Ventricular Tachycardia PAS
N/A
Active, not recruiting
62 participants
Started: Jul 24, 2023 · Completed: Nov 30, 2026
1 condition
1 sponsor
11 locations
NCT05835856
e-VITA: European-Japanese Virtual Coach for Smart Ageing (WAVE II)
NA
Active, not recruiting
240 participants
Started: Jul 24, 2023 · Completed: Mar 30, 2024
2 conditions
2 sponsors
4 locations
NCT05955482
Pragmatic Assessment of the NuvoAir Clinical Service in the Management of Patients With Chronic Obstructive Pulmonary Disease
N/A
Active, not recruiting
300 participants
Started: Jul 24, 2023 · Completed: Jul 31, 2025
2 conditions
1 sponsor
1 location
NCT05665543
Increasing HPV Vaccination in Pediatric, Adolescent, and Young Adult (PAYA) Cancer Survivors
NA
Active, not recruiting
162 participants
Started: Jul 24, 2023 · Completed: Aug 31, 2026
2 conditions
1 sponsor
1 location
NCT06728111
Unraveling Perioperative Myocardial Injury
N/A
Active, not recruiting
1,114 participants
Started: Jul 24, 2023 · Completed: Mar 1, 2027
2 conditions
1 sponsor
1 location
NCT05771155
Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio®
PHASE3
Active, not recruiting
750 participants
Started: Jul 24, 2023 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
NCT05570955
Deucravacitinib Adherence Study
NA
Active, not recruiting
40 participants
Started: Jul 24, 2023 · Completed: Feb 28, 2026
1 condition
2 sponsors
1 location
NCT05921084
MIND Diet to Improve Cognitive Function in Mild Stroke Patients
NA
Active, not recruiting
60 participants
Started: Jul 23, 2023 · Completed: Dec 1, 2025
5 conditions
2 sponsors
1 location
NCT05776004
Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial Pneumonia
PHASE2
Active, not recruiting
276 participants
Started: Jul 22, 2023 · Completed: Sep 7, 2026
1 condition
1 sponsor
90 locations
NCT06401733
Intensive Aerobic and Resistance Exercise Program (IAREP)
NA
Active, not recruiting
58 participants
Started: Jul 21, 2023 · Completed: Nov 4, 2025
4 conditions
2 sponsors
1 location
NCT05588960
Investigating Cerebral Oxygenation in the Newborn
N/A
Active, not recruiting
99 participants
Started: Jul 21, 2023 · Completed: May 31, 2027
3 conditions
4 sponsors
1 location
NCT05857397
A Collaborative Trial of Niraparib to Evaluate Patients With Ovarian Cancer in the Expanded Access Program in Latin America
N/A
Active, not recruiting
64 participants
Started: Jul 21, 2023 · Completed: May 31, 2025
1 condition
2 sponsors
16 locations
NCT05909904
A Study of Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma
PHASE2
Active, not recruiting
160 participants
Started: Jul 21, 2023 · Completed: May 28, 2026
2 conditions
1 sponsor
73 locations
NCT05289947
MLC1501 Study Assessing Efficacy in Post STrOke Subjects With mOtor Deficits
PHASE2
Active, not recruiting
300 participants
Started: Jul 21, 2023 · Completed: Sep 30, 2025
7 conditions
1 sponsor
11 locations
NCT05858320
The Impact of an Adaptive Patient-centered Web Application on Medication Optimization in HFrEF Patients
PHASE3
Active, not recruiting
225 participants
Started: Jul 21, 2023 · Completed: Jun 1, 2026
1 condition
4 sponsors
5 locations
Previous
1
More pages
110
111
112
113
114
115
116
More pages
431
Next